Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 11, Number 6—June 2005

Dispatch

Rifampicin Resistance in Tuberculosis Outbreak, London, England

Claire Jenkins*Comments to Author , Alleyna P. Claxton†, Robert J. Shorten*, Timothy D. McHugh*, and Stephen H. Gillespie*
Author affiliations: *Royal Free Hospital, London, United Kingdom; †Homerton Hospital, London, United Kingdom

Main Article

Figure 2

Suggested epidemiologic relationship between 6 cases of multidrug-resistant tuberculosis (MDR-TB). Resistance to rifampicin developed in patients 018, 483, and 915 while on therapy, whereas patients T7, 604, and 317 contracted primary MDR-TB. The type of mutation present in each patient's strain of MDR-TB is highlighted in bold.

Figure 2. . Suggested epidemiologic relationship between 6 cases of multidrug-resistant tuberculosis (MDR-TB). Resistance to rifampicin developed in patients 018, 483, and 915 while on therapy, whereas patients T7, 604, and 317 contracted primary MDR-TB. The type of mutation present in each patient's strain of MDR-TB is highlighted in bold.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO